Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial
| Autor: | Schechter, Meir a, b, c, Wiviott, Stephen D d, Raz, Itamar a, b, Goodrich, Erica L d, Rozenberg, Aliza a, b, Yanuv, Ilan a, b, Murphy, Sabina A d, Zelniker, Thomas A e, Fredriksson, Martin f, Johansson, Peter A f, Leiter, Lawrence A g, Bhatt, Deepak L h, McGuire, Darren K i, j, Wilding, John P H k, Gause-Nilsson, Ingrid A M f, Cahn, Avivit a, b, Langkilde, Anna Maria f, Sabatine, Marc S d, Mosenzon, Ofri a, b, * |
|---|---|
| Zdroj: | In The Lancet Diabetes & Endocrinology April 2023 11(4):233-241 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|